Summary
To study its pharmacokinetics and especially its biliary excretion, 14C-tolfenamic acid 9.84 µCi/100 mg was infused i.v. in 8 patients with a T-tube inserted in the common bile duct at choledocholithotomy 7–10 days prior to the study. Bile was collected in fractions by continuous suction over a 24 h period. Blood samples were taken and urine collected up to 48 h after the dose. Tolfenamic acid and its metabolites were separated by TLC and were quantitated by liquid scintillation counting. The pharmacokinetics of tolfenamic acid could be described by a two compartment open model with V1 of 3.67±0.68 l and Vss of 8.0±1.0 l. The total plasma clearance of tolfenamic acid averaged 106±8 ml/min and t1/2β was 1.38±0.32 h. A three compartment open model was required to describe the kinetics of total 14C. The plasma clearance of total 14C was 15.4±3.9 ml/min and its terminal half life averaged 19.0±4.1 h. The long half-life was caused by the slow elimination of tolfenamic acid metabolites. Four metabolites were measured in plasma and bile. The principal metabolites in bile were glucuronide/sulphate conjugates of hydroxylated derivatives of tolfenamic acid. The recovery of tolfenamic acid in bile was 1.1±0.3% of the dose, whereas the recovery of total 14C was 18.6±4.9%. The biliary clearances of tolfenamic acid and total 14C were 1.2±0.3 and 5.0±2.1 ml/min, respectively. Thus, biliary excretion plays a considerable part in the pharmacokinetics of tolfenamic acid.
Similar content being viewed by others
References
Pentikäinen PJ, Neuvonen PJ, Backman C (1981) Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent. Eur J Clin Pharmacol 19: 359–365
Hucker HB, Zacchei AG, Cox SV, Brodie DA, Cantwell NHR (1966) Studies on the absorption, distribution and excretion of indomethacin in various species. J Pharmacol Exp Ther 153: 237–249
Pentikäinen PJ, Penttilä A, Neuvonen PJ, Khalifah RG, Hignite CE (1982) Human metabolism of tolfenamic acid. I. Isolation, preliminary characterization and pharmacokinetics of tolfenamic acid and its metabolites. Eur J Drug Metabol Pharmacokinet 7: 259–267
Khalifah RG, Hignite CE, Pentikäinen PJ, Penttilä A, Neuvonen PJ (1982) Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamates. Eur J Drug Metabol Pharmacokinet 7: 269–276
Riegelman S, Loo JCK, Rowland M (1968) Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. J Pharm Sci 57: 117–123
Loo TL, Tanner BB, Housholder GE, Shepard BJ (1968) Some pharmacokinetic aspects of 5-(dimethyltriazeno)-imidazole-4-carboxamide in the dog. J Pharm Sci 57: 2126–2131
Brown RD, Manno JE (1978) ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 67: 1687–1691
Loo JCK, Riegelman S (1970) Assessment of pharmacokinetic constants from postinfusion blood curves obtained after i.v. infusion. J Pharm Sci 59: 53–55
Gibaldi M, Perrier D (1975) Pharmacokinetics. Marcel Dekker, New York
Glazko AJ (1967) Pharmacology of the fenamates. III. Metabolic disposition. Ann Phys Med 9: 23–36
Aarbakke J, Bakke OM, Milde EJ, Davies DS (1977) Disposition and oxidative metabolism of phenylbutazone in man. Eur J Clin Pharmacol 11: 359–366
Duggan DE, Hooke KF, Noll RM, Kwan KC (1975) Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem Pharmacol 25: 1749–1754
Kwan KC, Breault GO, Umbenhauer ER, McMahon FG, Duggan DE (1975) Kinetics of indomethacin absorption, elimination and enterohepatic circulation in man. J Pharm Biopharm 4: 255–280
Rollins DE, Klaassen CD (1979) Biliary excretion of drugs in man. Clin Pharmacokinet 4: 368–379
Pedersen SB, Alhede B, Buchardt O, Moller J, Bock K (1981) Tolfenamic acid. Detection and structure of urinary metabolites. Arzneimittelforsch Drug Res 31: 1944–1948
Thornell E, Jansson R, Kral JG, Svanvik J (1979) Inhibition of prostaglandin synthesis as a treatment for biliary pain. Lancet 1: 584
Thornell E, Jansson R, Svanvik J (1981) Indomethacin intravenously — A new way for effective relief of biliary pain: a double-blind study in man. Surgery 90: 468–472
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pentikäinen, P.J., Tokola, O., Alhava, E. et al. Pharmacokinetics of tolfenamic acid: Disposition in bile, blood and urine after intravenous administration to man. Eur J Clin Pharmacol 27, 349–354 (1984). https://doi.org/10.1007/BF00542174
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542174